Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy

We evaluated the efficacy and feasibility of the combination of gemcitabine plus vinorelbine in patients with platinum-based chemotherapy-refractory esophageal cancer. We enrolled 35 patients who received gemcitabine plus vinorelbine as second-line treatment after platinum-based chemotherapy failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yue-shen, Tian, Jing, Han, Yong, Han, Shu-mei, Shi, Sheng-bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838740/
https://www.ncbi.nlm.nih.gov/pubmed/27296953
http://dx.doi.org/10.3727/096504016X14618564639213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838740/
https://www.ncbi.nlm.nih.gov/pubmed/27296953
http://dx.doi.org/10.3727/096504016X14618564639213

Ejemplares similares